Top Markets
Coin of the day
Chongqing Lummy Pharmaceutical Co., Ltd. Chongqing Lummy Pharmaceutical Co., Ltd.

Chongqing Lummy Pharmaceutical Co., Ltd.

300006
Rang in Aktien #10090
Chongqing Lummy Pharmaceutical Co., Ltd. is a Chinese firm dedicated to the... Chongqing Lummy Pharmaceutical Co., Ltd. is a Chinese firm dedicated to the research, development, production, and distribution of a broad spectrum of pharmaceutical products. Its extensive portfolio encompasses treatments for various therapeutic areas, including oncology, infectious diseases (antibacterial, antiviral, and antifungal), liver support, and endocrine disorders. The company also develops and markets medications for the digestive, immune, blood, cardiovascular, and nervous systems, in addition to traditional Chinese patent medicines. Further offerings include electrolyte and acid-base balancing agents, nutritional supplements, large volume parenteral solutions, American ginseng preparations, and active pharmaceutical ingredients. Established in 1999, the company's headquarters are located in Chongqing, China.
Aktienkurs
$0.84484795
Zuletzt synchronisiert: 2026-08-28
Marktkapitalisierung
$892.08M
Veränderung (1 Tag)
-4.11%
Veränderung (1 Jahr)
27.37%
Land
CN
Handel Chongqing Lummy Pharmaceutical Co., Ltd. (300006)

Kategorie

Kursverlauf für Chongqing Lummy Pharmaceutical Co., Ltd. (300006)
Höchster Schlusskurs: $0.79 am 2026-08-01

Niedrigster Schlusskurs: $0.73 am 2009-10-01
Kursverlauf der Aktie von Chongqing Lummy Pharmaceutical Co., Ltd. von 2009 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 3.95%
2025 -2.54%
2024 34.82%
2023 -7.88%
2022 -36.89%
2021 -24.49%
2020 66.12%
2019 31.46%
2018 -41.72%
2017 -21.56%
2016 -18.31%
2015 8.41%
2014 22.10%
2013 41.30%
2012 -5.30%
2011 11.98%
2010 4.67%
2009 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$1.17K 59.57%
US
$268.33 51.45%
US
$256.07 21.71%
US
$476.00 38.97%
CH
$148.28 76.27%
US